From: The roles of tissue resident macrophages in health and cancer
Cell | Signaling pathway | Key function | Refs. |
---|---|---|---|
Aveolar macrophage | P16/CXCR1 | Suppress the cytotoxic T cell response to pro-tumor | [48] |
ROS/BACH1/PDLIM2/STAT3 | Promote tumor growth | [50] | |
INHBA/activin A | Anti-tumor effects | [52] | |
SOCS3/STAT3 | Inhibition of proliferation and survival of cancer cells | [51] | |
Upregulation IL-12β, IL-1α, and IL-1β | Pro-inflammatory in metastasis | [57] | |
Upregulation of Smad3, TGF-β and downregulation of Smad7 | Anti-inflammatory in metastasis | [57] | |
WNT/β-catenin/TNF-α | Pro-metastatic environment | [58] | |
CXCL10/CXCR3 and TLR4/CCL12 | Suppresses lung metastasis | [59] | |
Kupffer cell | FOLR2+ macrophage express CXCL12, CXCL16, and CD86 | Engage in immunosuppressive interactions with Tregs | [93] |
PD-L1/PD-1 and TIM-3/Galectin-9 | Inhibit the antitumor response | ||
TREM-1 deficiency reduced IL-1β, IL-6, CCL2, and CXCL10 | Contribute to anti-tumor response | [97] | |
ROS and TNF | Cause intrahepatic cholangiocarcinoma | [73] | |
Early-stage KCs depletion modulated INOS and VEGF | Enhance metastasis progression | [99] | |
Late-stage KCs depletion increased CD3 cells infiltration | Impede metastasis growth | [99] | |
Mafb- and Maf- dual knockout | Exhibit anti-tumor response by reverse KCs function | [101] | |
Microglia | EGF and STI1 | Promote glioblastoma cell invasion | |
TGF-β | Promote glioma cells migration | [145] | |
CCL2/CCR2/IL-6 | Promote glioma invasion | ||
IL-6/JAK2/STAT3 | Promote a pro-metastatic environment | [154] | |
LPS-activated | Induce apoptosis in metastatic lung cancer cells | [153] | |
ANXA1/STAT3 | Enhance metastatic cell migration | [155] | |
TGF-β | Fosters tolerance towards metastatic melanoma cells | [156] | |
CPG-C | Combats brain metastases | [157] | |
Langerhans | CD4+ and CD8+ T cells enhance production of IFN-γ | Anti-tumor immune response | |
TLR3 ligand polyinosine | Enhance the CD8+ T cell response | [201] | |
PAK1 | Alter LCs functions in skin carcinogenesis | [206] | |
CD207/liposomes 22 vaccine | Induce protective immune responses against tumors | [208] | |
Gut resident macrophage | MR, CD163/CCL17, CCL22, CCL24, IL-10 and TGF-β | Promote tumor development | [230] |
C-MYC/VEGF, HIF-1α, and TGF-β | Regulates the expression of pro-tumoral genes | [231] | |
IL-34 and IL-10 | Enhance tumor proliferation | [236] | |
CCR2-independent F4/80+MHCIIlo subset | Promote tumor progression | [237] | |
ERK/S100A8/A9 | Enhance tumor migration | [240] | |
JAK2/STAT3/FOXQ1 | Promote its migration and invasion | [241] |